Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Coquelusedal Adulte
- Development stage
- Unknown
- Lead developer
- Laboratoires Elerté
- Modality
- Small Molecules
- Administration
- Rectal
01
Overview
Coquelusedal Adulte is a herbal medicinal product formulated as a suppository for rectal administration. It is indicated as an adjunctive treatment for benign acute bronchial disorders in adults, primarily to alleviate cough and respiratory congestion. The formulation contains hydroalcoholic extracts of *Grindelia robusta* and *Gelsemium sempervirens*. Grindelia is traditionally recognized for its expectorant and antispasmodic properties, facilitating the clearance of mucus and reducing bronchial spasms, while Gelsemium provides a sedative effect on the respiratory tract. Developed by Laboratoire ELERTE, it is a long-standing treatment in the French pharmaceutical market for mild respiratory conditions.
- Brand names
- Coquelusedal Adulte
- Other names
- Coquelusedal
Beyond the preview
Go deeper on Coquelusedal Adulte.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Coquelusedal Adulte.